Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1586/14737159.2014.946908 http://scihub22266oqcxt.onion/10.1586/14737159.2014.946908 C4480673!4480673!25098554     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25098554&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Mol+Diagn 2014 ; 14 (7): 803-17 Nephropedia Template TP {{tp|p=25098554|t=2014. DNA markers in molecular diagnostics for hepatocellular carcinoma |pdf=|usr=}}{{25098554}} gab.com Text DNA markers in molecular diagnostics for hepatocellular carcinoma JO: Expert Rev Mol Diagn http://www.kidney.de/pget.php?&tw=1&pmid=25098554 #FOAvip Hepatocellular carcinoma (HCC) is the one of the leading causes of cancer mortality in the world, mainly due to the difficulty of early detection and limited therapeutic options. The implementation of HCC surveillance programs in well-defined, high-risk populations were only able to detect about 40?50% of HCC at curative stages (Barcelona Clinic Liver Cancer stages 0 & 1) due to the low sensitivities of the current screening methods. The advance of sequencing technologies has identified numerous modifications as potential candidate DNA markers for diagnosis/surveillance. Here we aim to provide an overview of the DNA alterations that result in activation of cancer pathways known to potentially drive HCC carcinogenesis and to summarize performance characteristics of each DNA marker in the periphery (blood or urine) for HCC screening. Twit Text FOAVip DNA markers in molecular diagnostics for hepatocellular carcinoma ????Expert Rev Mol Diagn http://www.kidney.de/pget.php?&tw=1&pmid=25098554 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25098554 #FOAvip English Wikipedia <ref>{{Cite pmid|25098554}}</ref> DNA markers in molecular diagnostics for hepatocellular carcinoma #MMPMID25098554 Su YH; Lin SY; Song W; Jain S Expert Rev Mol Diagn 2014[Sep]; 14 (7): 803-17 PMID25098554show ga Hepatocellular carcinoma (HCC) is the one of the leading causes of cancer mortality in the world, mainly due to the difficulty of early detection and limited therapeutic options. The implementation of HCC surveillance programs in well-defined, high-risk populations were only able to detect about 40?50% of HCC at curative stages (Barcelona Clinic Liver Cancer stages 0 & 1) due to the low sensitivities of the current screening methods. The advance of sequencing technologies has identified numerous modifications as potential candidate DNA markers for diagnosis/surveillance. Here we aim to provide an overview of the DNA alterations that result in activation of cancer pathways known to potentially drive HCC carcinogenesis and to summarize performance characteristics of each DNA marker in the periphery (blood or urine) for HCC screening. äDNA markers in molecular diagnostics for hepatocellular carcinoma (epmc).pdf DeepDyve Pubget Overpricing